Prelude Capital Management’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
LP
CC
PF
FTCM
AA
AGC
LA
Prelude Capital Management's FSNB.WS Position: Q4 2021 in Review
Prelude Capital Management sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2021, closing a stake of 12,299 shares — an estimated $8K sold.
Prelude Capital Management first reported a position in FSNB.WS in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 71 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2021.
- Prelude Capital Management reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
- Prelude Capital Management sold 12,299 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2021, an estimated $8K.
- Prelude Capital Management first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q3 2021 and held it in 1 quarter.
- Prelude Capital Management's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $8K in Q3 2021.
- 71 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2021.
Based on Prelude Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.